1887

Chapter 2 : Evolution of Neuropsychological Issues in HIV-1 Infection during the HAART Era

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Evolution of Neuropsychological Issues in HIV-1 Infection during the HAART Era, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815691/9781555813697_Chap02-1.gif /docserver/preview/fulltext/10.1128/9781555815691/9781555813697_Chap02-2.gif

Abstract:

This chapter summarizes the neuropsychological (NP) findings from the highly active antiretroviral therapy (HAART), and pre-HAART eras, including a discussion of the impact that impairment has on “real-world” functioning. Reports from a number of cohorts suggest that, in the HAART era, a subset of individuals transition in and out of impairment over time, raising the possibility that neurocognitive dysfunction in HIV-1 infection may be neither static nor chronically progressive but in the mildest forms may exhibit a fluctuating, relapsing/remitting course, similar to demyelinating disorders. HIV-1 infection of the brain is characterized by HIV encephalitis (HIVE), or the presence of multinucleated giant cells, microglial nodules, astrocytosis, and myelin pallor. Importantly, in the Heaton and coworkers study, both the NP and functional batteries were independent predictors of “real-world” functional status, based on complaints of cognitive difficulties, level of dependence/independence in instrumental activities of daily living, and employment status. Several brief cognitive screening techniques have been developed for situations in which a full or focused NP evaluation is not indicated or not feasible. Most research studies of NP function in HIV-1 infection utilize between-group mean comparisons of test scores on individual measures. Some controversy still exists regarding whether affective/ mood disorders, such as major depression and anxiety, interact with neurocognitive impairment. Ivnik and coworkers showed that large positive and negative test score changes were not uncommon for individuals across time, even though test-retest means stay relatively stable across the entire sample.

Citation: Marcotte T, Scott J. 2009. Evolution of Neuropsychological Issues in HIV-1 Infection during the HAART Era, p 29-44. In Goodkin K, Shapshak P, Verma A (ed), The Spectrum of Neuro-AIDS Disorders. ASM Press, Washington, DC. doi: 10.1128/9781555815691.ch2

Key Concept Ranking

Human immunodeficiency virus 1
0.5408927
Tumor Necrosis Factor alpha
0.4836101
Highly Active Antiretroviral Therapy
0.45083755
Hepatitis C virus
0.41010785
0.5408927
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1.
FIGURE 1.

Estimate for distribution of time to neurocognitive impairment (in years) on or prior to 31 December 1995 (pre-HAART) versus on or after 1 January 1996 (post-HAART). (From .)

Citation: Marcotte T, Scott J. 2009. Evolution of Neuropsychological Issues in HIV-1 Infection during the HAART Era, p 29-44. In Goodkin K, Shapshak P, Verma A (ed), The Spectrum of Neuro-AIDS Disorders. ASM Press, Washington, DC. doi: 10.1128/9781555815691.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2.
FIGURE 2.

Reduction (improvement) in NP performance (GDS) among subjects with and without suppressed CSF HIV RNA viral load at follow-up. The box-and-whisker plots show the median (center line), interquartile range (box), and 5th and 95th percentiles (whiskers). (From .)

Citation: Marcotte T, Scott J. 2009. Evolution of Neuropsychological Issues in HIV-1 Infection during the HAART Era, p 29-44. In Goodkin K, Shapshak P, Verma A (ed), The Spectrum of Neuro-AIDS Disorders. ASM Press, Washington, DC. doi: 10.1128/9781555815691.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3.
FIGURE 3.

Relationship between dendritic complexity in the midfrontal region and blinded clinical rating of global neurocognitive functioning. (From .)

Citation: Marcotte T, Scott J. 2009. Evolution of Neuropsychological Issues in HIV-1 Infection during the HAART Era, p 29-44. In Goodkin K, Shapshak P, Verma A (ed), The Spectrum of Neuro-AIDS Disorders. ASM Press, Washington, DC. doi: 10.1128/9781555815691.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 4.
FIGURE 4.

Performances of HIV (open columns), HIV NP normal (gray columns), and HIV NP impaired (black columns) subjects on driving simulator measures of accidents and navigational errors and an on-road driving evaluation. (Adapted from .)

Citation: Marcotte T, Scott J. 2009. Evolution of Neuropsychological Issues in HIV-1 Infection during the HAART Era, p 29-44. In Goodkin K, Shapshak P, Verma A (ed), The Spectrum of Neuro-AIDS Disorders. ASM Press, Washington, DC. doi: 10.1128/9781555815691.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555815691.ch02
1. Achim, C. L.,, R. Wang,, D. K. Miners, and, C. A. Wiley. 1994. Brain viral burden in HIV infection. J. Neuropathol. Exp. Neurol. 53:284294.
2. Albert, S. M.,, K. Marder,, G. Dooneief,, K. Bell,, M. Sano,, G. Todak, and, Y. Stern. 1995. Neuropsychologic impairment in early HIV infection. A risk factor for work disability. Arch. Neurol. 52:525530.
3. Albert, S. M.,, C. M. Weber,, G. Todak,, C. Polanco,, R. Clouse,, M. McElhiney,, J. Rabkin,, Y. Stern, and, K. Marder. 1999. An observed performance test of medication management ability in HIV: relation to neuropsychological status and medication adherence outcomes. AIDS Behav. 3:121128.
4. American Academy of Neurology AIDS Task Force. 1991. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 41:778785.
5. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Association, Washington, DC.
6. Andrade, A.,, H. F. McGruder,, A. W. Wu,, S. A. Celano,, R. L. Skolasky, Jr.,, O. A. Selnes,, I. Huang, and, J. C. McArthur. 2005. A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment. Clin. Infect. Dis. 41:875882.
7. Antinori, A.,, G. Arendt,, J. T. Becker,, B. J. Brew,, D. A. Byrd,, M. Cherner,, D. B. Clifford,, P. Cinque,, L. G. Epstein,, K. Goodkin,, M. Gisslen,, I. Grant,, R. K. Heaton,, J. Joseph,, K. Marder,, C. M. Marra,, J. C. McArthur,, M. Nunn,, R. W. Price,, L. Pulliam,, K. R. Robertson,, N. Sacktor,, V. Valcour, and, V. E. Wojna. 2007. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:17891799.
8. Antinori, A.,, M. L. Giancola,, S. Grisetti,, F. Soldani,, L. Alba,, G. Liuzzi,, A. Amendola,, M. Capobianchi,, V. Tozzi, and, C. F. Perno. 2002. Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients. AIDS 16:18671876.
9. Atkinson, J. H.,, and I. Grant. 1994. Natural history of neuropsychiatric manifestations of HIV disease. Psychiatr. Clin. N. Am. 17:1733.
10. Ball, K.,, C. Owsley,, M. E. Sloane,, D. L. Roenker, and, J. R. Bruni. 1993. Visual attention problems as a predictor of vehicle crashes in older drivers. Investig. Ophthalmol. Vis. Sci. 34:31103423.
11. Bechara, A.,, and E. M. Martin. 2004. Impaired decision making related to working memory deficits in individuals with substance addictions. Neuropsychology 18:152162.
12. Becker, J. T.,, R. Caldararo,, O. L. Lopez,, M. A. Dew,, S. K. Dorst, and, G. Banks. 1995. Qualitative features of the memory deficit associated with HIV infection and AIDS: cross-validation of a discriminant function classification scheme. J. Clin. Exp. Neuropsychol. 17:134142.
13. Becker, J. T.,, O. L. Lopez,, M. A. Dew, and, H. J. Aizenstein. 2004. Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS 18(Suppl 1):S11S18.
14. Boccellari, A.,, and P. Zeifert. 1994. Management of neurobehavioral impairment in HIV-1 infection. Psychiatr. Clin. N. Am. 17:183203.
15. Bornstein, R. A.,, H. A. Nasrallah,, M. F. Para,, C. C. Whitacre,, P. Rosenberger,, R. J. Fass, and, R. Rice. 1992. Neuropsychological performance in asymptomatic HIV infection. J. Neuropsychiatry Clin. Neurosci. 4:386394.
16. Bottiggi, K. A.,, J. J. Chang,, F. A. Schmitt,, M. J. Avison,, Y. Mootoor,, A. Nath, and, J. R. Berger. 2007. The HIV Dementia Scale: predicting power in mild dementia and HAART. J. Neurol. Sci. 260:1115.
17. Bouwman, F. H.,, R. L. Skolasky,, D. Hes,, O. A. Selnes,, J. D. Glass,, T. E. Nance-Sproson,, W. Royal,, G. J. Dal Pan, and, J. C. McArthur. 1998. Variable progression of HIV-associated dementia. Neurology 50:18141820.
18. Brandt, J.,, and R. H. B. Benedict. 2001. Hopkins Verbal Learning Test-Revised. Professional manual. Psychological Assessment Resources, Inc., Lutz, FL.
19. Brew, B. J. 2004. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 18(Suppl 1):S75S78.
20. Butters, N.,, I. Grant,, J. Haxby,, L. L. Judd,, A. Martin,, J. McClelland,, W. Pequegnat,, D. Schacter, and, E. Stover. 1990. Assessment of AIDS-related cognitive changes: recommendations of the NIMH Workshop on Neuropsychological Assessment Approaches. J. Clin. Exp. Neuropsychol. 12:963978.
21. Carey, C. L.,, S. P. Woods,, R. Gonzalez,, E. Conover,, T. D. Marcotte,, I. Grant,, R. K. Heaton,and the HNRC Group. 2004a. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J. Clin. Exp. Neuropsychol. 26:307319.
22. Carey, C. L.,, S. P. Woods,, J. D. Rippeth,, R. Gonzalez,, D. J. Moore,, T. D. Marcotte,, I. Grant,, R. K. Heaton, and the HNRC Group. 2004b. Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. Clin. Neuropsychol. 18:234248.
23. Carey, C. L.,, S. P. Woods,, J. D. Rippeth,, R. K. Heaton,, I. Grant,and the HNRC Group. 2006. Prospective memory in HIV-1 infection. J. Clin. Exp. Neuropsychol. 28:536548.
24. Carter, S. L.,, S. B. Rourke,, S. Murji,, D. Shore, and, B. P. Rourke. 2003. Cognitive complaints, depression, medical symptoms, and their association with neuropsychological functioning in HIV infection: a structural equation model analysis. Neuropsychology 17:410419.
25. Cherner, M.,, R. J. Ellis,, D. Lazzaretto,, C. Young,, M. R. Mindt,, J. H. Atkinson,, I. Grant,, R. K. Heaton, and the HNRC Group. 2004. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. AIDS 18(Suppl 1):S27S34.
26. Cherner, M.,, L. Cysique,, R. K. Heaton,, T. D. Marcotte,, R. J. Ellis,, E. Masliah,, I. Grant, and the HNRC Group. 2007. Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders. J. Neurovirol. 13:2328.
27. Cherner, M.,, S. Letendre,, R. K. Heaton,, J. Durelle,, J. Marquie-Beck,, B. Gragg,, I. Grant, and the HNRC Group. 2005. Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology 64:13431347.
28. Cherner, M.,, E. Masliah,, R. J. Ellis,, T. D. Marcotte,, D. J. Moore,, I. Grant,, R. K. Heaton, and the HNRC Group. 2002. Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology 59:15631567.
29. Chesney, M. A.,, J. R. Ickovics,, D. B. Chambers,, A. L. Gifford,, J. Neidig,, B. Zwickl,, A. W. Wu, et al. 2000. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care 12:255266.
30. Childers, M. E.,, R. J. Ellis,, R. Deutsch,, T. Wolfson,, I. Grant, and the HNRC Group. 2002. The utility and limitations of the HIV dementia scale. J. Int. Neuropsychol. Soc. 8:160.
31. Childs, E. A.,, R. H. Lyles,, O. A. Selnes,, B. Chen,, E. N. Miller,, B. A. Cohen,, J. T. Becker,, J. Mellors, and, J. C. McArthur. 1999. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 52:607613.
32. Clifford, D. B.,, J. C. McArthur,, G. Schifitto,, K. Kieburtz,, M. P. McDermott,, S. Letendre,, B. A. Cohen,, K. Marder,, R. J. Ellis, and, C. M. Marra. 2002. A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment. Neurology 59:15681573.
33. Cohen, R. A.,, R. Boland,, R. Paul,, K. T. Tashima,, E. E. Schoenbaum,, D. D. Celentano,, P. Schuman,, D. K. Smith, and, C. C. Carpenter. 2001. Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS 15:341345.
34. Cysique, L. A.,, R. Deutsch,, J. A. Atkinson,, C. Young,, T. D. Marcotte,, L. Dawson,, I. Grant,, R. K. Heaton, and the HNRC Group. 2007. Incident major depression does not affect neuropsychological functioning in HIV-infected men. J. Int. Neuropsychol. Soc. 13:111.
35. Cysique, L. A.,, P. Maruff, and, B. J. Brew. 2004a. Antiretroviral therapy in HIV infection: are neurologically active drugs important? Arch. Neurol. 61:16991704.
36. Cysique, L. A.,, P. Maruff, and, B. J. Brew. 2004b. Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J. Neurovirol. 10:350357.
37. Cysique, L. A.,, P. Maruff, and, B. J. Brew. 2006. Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology 66:14471450.
38. Dal Pan, G. J.,, H. Farzadegan,, O. Selnes,, D. R. Hoover,, E. N. Miller,, R. L. Skolasky,, T. E. Nance-Sproson, and, J. C. McArthur. 1998. Sustained cognitive decline in HIV infection: relationship to CD4+ cell count, plasma viremia and p24 antigenemia. J. Neurovirol. 4:9599.
39. Detels, R.,, A. Munoz,, G. McFarlane,, L. A. Kingsley,, J. B. Margolick,, J. Giorgi,, L. K. Schrager, and, J. P. Phair. 1998. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. JAMA 280:14971503.
40. Deutsch, R.,, R. J. Ellis,, J. A. McCutchan,, T. D. Marcotte,, S. Letendre,, I. Grant, and the HNRC Group. 2001. AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy. AIDS 15:18981899.
41. Dore, G. J.,, P. K. Correll,, Y. Li,, J. M. Kaldor,, D. A. Cooper, and, B. J. Brew. 1999. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 13:12491253.
42. Dore, G. J.,, A. McDonald,, Y. Li,, J. M. Kaldor, and, B. J. Brew. 2003. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 17:15391545.
43. Duchek, J. M.,, L. Hunt,, K. Ball,, V. Buckles, and, J. C. Morris. 1998. Attention and driving performance in Alzheimer’s disease. J. Gerontol. 53:P130P141.
44. Ellis, R. J.,, R. Deutsch,, R. K. Heaton,, T. D. Marcotte,, J. A. McCutchan,, J. A. Nelson,, I. Abramson,, L. J. Thal,, J. H. Atkinson,, M. R. Wallace,, I. Grant, et al. 1997a. Neurocognitive impairment is an independent risk factor for death in HIV infection. Arch. Neurol. 54:416424.
45. Ellis, R. J.,, K. Hsia,, S. A. Spector,, J. A. Nelson,, R. K. Heaton,, M. R. Wallace,, I. Abramson,, J. H. Atkinson,, I. Grant,, J. A. McCutchan, et al. 1997b. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann. Neurol. 42:679688.
46. Ellis, R. J.,, D. J. Moore,, M. E. Childers,, S. Letendre,, J. A. McCutchan,, T. Wolfson,, S. A. Spector,, K. Hsia,, R. K. Heaton, and, I. Grant. 2002. Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch. Neurol. 59:923928.
47. Everall, I. P.,, R. K. Heaton,, T. D. Marcotte,, R. J. Ellis,, J. A. McCutchan,, J. H. Atkinson,, I. Grant,, M. Mallory, and, E. Masliah. 1999. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. Brain Pathol. 9:209217.
48. Farinpour, R.,, E. M. Martin,, M. Seidenberg,, D. L. Pitrak,, K. J. Pursell,, K. M. Mullane,, R. M. Novak, and, M. Harrow. 2000. Verbal working memory in HIV-seropositive drug users. J. Int. Neuropsychol. Soc. 6:548555.
49. Ferrando, S.,, W. van Gorp,, M. McElhiney,, K. Goggin,, M. Sewell, and, J. Rabkin. 1998. Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. AIDS 12:F65F70.
50. Ferrando, S. J.,, J. G. Rabkin,, W. van Gorp,, S. H. Lin, and, M. McElhiney. 2003. Longitudinal improvement in psychomotor processing speed is associated with potent combination antiretroviral therapy in HIV-1 infection. J. Neuropsychiatry Clin. Neurosci. 15:208214.
51. Folstein, M. 1983. The Mini-Mental State Exam, p. 47–51. In T. Crook,, S. Ferris, and, R. Bartus (ed.), Assessment in Geriatric Psychopharmacology. Mark Powley, New Canaan, CT.
52. Folstein, M. F.,, S. E. Folstein, and, P. R. McHugh. 1975. “Mini-Mental State”: A practical method for grading the cognitive state of outpatients for the clinician. J. Psychiatr. Res. 12:189198.
53. Gardner, R.,, S. Oliver-Munoz,, L. Fisher, and, L. Empting. 1981. Mattis Dementia Rating Scale: internal reliability study using a diffusely impaired population. J. Clin. Neuropsychol. 3:271275.
54. Giancola, M. L.,, P. Lorenzini,, P. Balestra,, D. Larussa,, F. Baldini,, A. Corpolongo,, P. Narciso,, R. Bellagamba,, V. Tozzi, and, A. Antinori. 2006. Neuroactive antiretroviral drugs do not influence neurocognitive performance in less advanced HIV-infected patients responding to highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 41:332337.
55. Gladsjo, J. A.,, C. C. Schuman,, J. D. Evans,, G. M. Peavy,, S. W. Miller, and, R. K. Heaton. 1999. Norms for letter and category fluency: demographic corrections for age, education, and ethnicity. Assessment 6:147178.
56. Glass, J. D.,, S. L. Wesselingh,, O. A. Selnes, and, J. C. McArthur. 1993. Clinical-neuropathologic correlations in HIV-associated dementia. Neurology 43:22302237.
57. Goodkin, K.,, F. L. Wilkie,, M. Concha,, C. H. Hinkin,, S. Symes,, T. T. Baldewicz,, D. Asthana,, R. K. Fujimura,, D. Lee,, M. H. van Zuilen,, I. Khamis,, P. Shapshak, and, C. Eisdorfer. 2001. Aging and neuro-AIDS conditions and the changing spectrum of HIV-1-associated morbidity and mortality. J. Clin. Epidemiol. 54(Suppl 1):S35S43.
58. Gonzalez, E.,, B. H. Rovin,, L. Sen,, G. Cooke,, R. Dhanda,, S. Mummidi,, H. Kulkarni,, M. J. Bamshad,, V. Telles,, S. A. Anderson,, E. A. Walter,, K. T. Stephan,, M. Deucher,, A. Mangano,, R. Bologna,, S. S. Ahuja,, M. J. Dolan, and, S. K. Ahuja. 2002. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc. Natl. Acad. Sci. U.S.A. 99:1379513800.
59. Grant, I.,, and J. H. Atkinson. 1995. Psychiatric aspects of acquired immune deficiency syndrome, p. 1644–1669. In H. I. Kaplan and, B. J. Sadock (ed.), Comprehensive Textbook of Psychiatry/V1, vol. 2, section 29.2. Williams and Wilkins, Baltimore, MD.
60. Grant, I.,, J. H. Atkinson,, J. R. Hesselink,, C. J. Kennedy,, D. D. Richman,, S. A. Spector, and, J. A. McCutchan. 1987. Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Ann. Intern. Med. 107:828836.
61. Grant, I.,, R. A. Olshen,, J. H. Atkinson,, R. K. Heaton,, J. Nelson,, J. A. McCutchan, and, J. D. Weinrich. 1993. Depressed mood does not explain neuropsychological deficits in HIV-infected persons. Neuropsychology 7:5361.
62. Hasenauer, D.,, O. Selnes,, T. E. Nance-Sproson,, D. Esposito, and, J. C. McArthur. 1996. Psychomotor slowing in HIV-associated dementia (HAD): central nervous system (CNS) dysfunction or fatigue? J. Neurovirol. 2:39.
63. Heaton, R. K.,, I. Grant,, N. Butters,, D. A. White,, D. Kirson,, J. H. Atkinson,, J. A. McCutchan,, M. J. Taylor,, M. D. Kelly,, R. J. Ellis,, T. Wolfson,, R. Velin,, T. D. Marcotte,, J. R. Hesselink,, T. L. Jernigan,, J. Chandler,, M. Wallace,, I. Abramson,and the HNRC Group. 1995. The HNRC 500—Neuropsychology of HIV infection at different disease stages. J. Int. Neuropsychol. Soc. 1:231251.
64. Heaton, R. K.,, D. Kirson,, R. A. Velin,, I. Grant, and the HNRC Group. 1994a. The utility of clinical ratings for detecting cognitive change in HIV infection, p. 188–206. In I. Grant and, A. Martin (ed.), Neuropsychology of HIV Infection. Oxford University Press, New York, NY.
65. Heaton, R. K.,, and T. D. Marcotte. 2000. Clinical neuropsychological tests and assessment techniques, p. 27–52. In F. Boller,, J. Grafman, and, G. Rizzolatti (ed.), Handbook of Neuropsychology. Elsevier Science B.V., Amsterdam, The Netherlands.
66. Heaton, R. K.,, T. D. Marcotte,, M. R. Mindt,, J. Sadek,, D. J. Moore,, H. Bentley,, J. A. McCutchan,, C. Reicks,, I. Grant, and the HNRC Group. 2004a. The impact of HIV-associated neuropsychological impairment on everyday functioning. J. Int. Neuropsychol. Soc. 10:317331.
67. Heaton, R. K.,, T. D. Marcotte,, D. A. White,, D. Ross,, K. Meredith,, M. J. Taylor,, R. Kaplan, and, I. Grant. 1996. Nature and vocational significance of neuropsychological impairment associated with HIV infection. Clin. Neuropsychol. 10:114.
68. Heaton, R. K.,, S. W. Miller,, M. J. Taylor, and, I. Grant. 2004b. Revised Comprehensive Norms for an Expanded Halstead-Reitan Battery: Demographically Adjusted Neuropsychological Norms for African American and Caucasian Adults. Psychological Assessment Resources, Inc., Lutz, FL.
69. Heaton, R. K.,, R. A. Velin,, J. A. McCutchan,, S. J. Gulevich,, J. H. Atkinson,, M. R. Wallace,, H. P. D. Godfrey,, D. A. Kirson,, I. Grant, and the HNRC Group. 1994b. Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. Psychosom. Med. 56:817.
70. Heseltine, P. N.,, K. Goodkin,, J. H. Atkinson,, B. Vitiello,, J. Rochon,, R. K. Heaton,, E. M. Eaton,, F. L. Wilkie,, E. Sobel,, S. J. Brown,, D. Feaster,, L. Schneider,, W. L. Goldschmidts, and, E. S. Stover. 1998. Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment. Arch. Neurol. 55:4151.
71. Hinkin, C. H.,, S. A. Castellon,, R. S. Durvasula,, D. J. Hardy,, M. N. Lam,, K. I. Mason,, D. Thrasher,, M. B. Goetz, and, M. Stefaniak. 2002a. Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology 59:19441950.
72. Hinkin, C. H.,, D. J. Hardy,, K. I. Mason,, S. A. Castellon,, M. N. Lam,, M. Stefaniak, and, B. Zolnikov. 2002b. Verbal and spatial working memory performance among HIV-infected adults. J. Int. Neuropsychol. Soc. 8:532538.
73. Hinkin, C. H.,, W. G. van Gorp,, P. Satz,, J. D. Weisman,, J. Thommes, and, S. Buckingham. 1992. Depressed mood and its relationship to neuropsychological test performance in HIV-1 seropositive individuals. J. Clin. Exp. Neuropsychol. 14:289297.
74. Hiscock, M.,, and C. K. Hiscock. 1989. Refining the forced-choice method for the detection of malingering. J. Clin. Exp. Neuropsychol. 11:967974.
75. Ivnik, R. J.,, G. E. Smith,, J. F. Malec, and, R. C. Petersen. 1995. Long term stability and intercorrelations of cognitive abilities in older persons. Psychol. Assess. 7:155161.
76. Jacobs, J. W.,, M. R. Bernhard,, A. Delgado, and, J. J. Strain. 1977. Screening for organic mental syndromes in the medically ill. Ann. Intern. Med. 86:4046.
77. Kaplan, R. M.,, J. P. Anderson,, T. L. Patterson,, J. A. McCutchan,, J. D. Weinrich,, R. K. Heaton,, J. H. Atkinson,, L. Thal,, J. Chandler,, I. Grant, and the HNRC Group. 1995. Validity of the Quality of Well-Being Scale for persons with human immunodeficiency virus infection. Psychosom. Med. 57:138147.
78. Kaplan, R. M.,, T. L. Patterson,, D. N. Kerner,, J. H. Atkinson,, R. K. Heaton,, I. Grant, et al. 1997. The Quality of Well-Being scale in asymptomatic HIV-infected patients. Qual. Life Res. 6:507514.
79. Kissel, E. C.,, N. D. Pukay-Martin, and, R. A. Bornstein. 2005. The relationship between age and cognitive function in HIV-infected men. J. Neuropsychiatry Clin. Neurosci. 17:180184.
80. Klove, H. 1963. Clinical neuropsychology, p. 1647–1658 In F. M. Forster (ed.), The Medical Clinics of North America. Saunders, New York, NY.
81. Langford, D.,, A. Adame,, A. Grigorian,, I. Grant,, J. A. McCutchan,, R. J. Ellis,, T. D. Marcotte,, E. Masliah, and the HNRC Group. 2003. Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J. Acquir. Immune Defic. Syndr. 34:467474.
82. Letendre, S.,, J. Marquie-Beck,, E. Capparelli,, B. Best,, D. Clifford,, A. Collier,, B. B. Gelman,, J. C. McArthur,, J. A. McCutchan,, S. Morgello,, D. Simpson,, I. Grant,, R. J. Ellis,and the CHARTER Group. 2008. Validation of the CNS Penetrati-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch. Neurol. 65:6570.
83. Letendre, S. L.,, J. A. McCutchan,, M. E. Childers,, S. P. Woods,, D. Lazzaretto,, R. K. Heaton,, I. Grant, and, R. J. Ellis. 2004. Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann. Neurol. 56:416423.
84. Lojek, E.,, and R. A. Bornstein. 2005. The stability of neurocognitive patterns in HIV infected men: classification considerations. J. Clin. Exp. Neuropsychol. 27:665682.
85. Marcotte, T. D.,, R. Deutsch,, J. A. McCutchan,, D. J. Moore,, S. Letendre,, R. J. Ellis,, M. R. Wallace,, R. K. Heaton,, I. Grant,and the HNRC Group. 2003. Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion. Arch. Neurol. 60:14061412.
86. Marcotte, T. D.,, R. K. Heaton,, R. J. Ellis,, I. Grant, and the HNRC Group. 2005. Neuropsychological impairment in HIV infection: how typical is the “typical profile”? J. Int. Neuropsychol. Soc. 11:21.
87. Marcotte, T. D.,, R. K. Heaton,, R. Gonzalez,, C. Reicks,, I. Grant, and the HNRC Group. 2000. HIV-associated neurocognitive deficits impact on-road driving abilities. J. Neurovirol. 6:268.
88. Marcotte, T. D.,, R. K. Heaton,, T. Wolfson,, M. J. Taylor,, O. Alhassoon,, K. Arfaa,, R. J. Ellis,, I. Grant, and the HNRC Group. 1999. The impact of HIV-related neuropsychological dysfunction on driving behavior. J. Int. Neuropsychol. Soc. 5:579592.
89. Marcotte, T. D.,, D. Lazzaretto,, J. C. Scott,, E. Roberts,, S. P. Woods,, S. Letendre,and the HNRC Group. 2006. Visual attention deficits are associated with driving accidents in cognitively-impaired HIV-infected individuals. J. Clin. Exp. Neuropsychol. 28:1328.
90. Marcotte, T. D.,, and J. C. Scott. 2004. The assessment of driving abilities. Adv. Transportation Studies 4(Suppl.):7990.
91. Marcotte, T. D.,, T. Wolfson,, T. J. Rosenthal,, R. K. Heaton,, R. Gonzalez,, R. J. Ellis,, I. Grant, and the HNRC Group. 2004. A multimodal assessment of driving performance in HIV infection. Neurology 63:14171422.
92. Marra, C. M.,, D. Lockhart,, J. R. Zunt,, M. Perrin,, R. W. Coombs, and, A. C. Collier. 2003. Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy. Neurology 60:13881390.
93. Martin, E. M.,, D. L. Pitrak,, W. Weddington,, N. A. Rains,, G. Nunnally,, H. Nixon,, S. Grbesic,, J. Vassileva, and, A. Bechara. 2004. Cognitive impulsivity and HIV serostatus in substance dependent males. J. Int. Neuropsychol. Soc. 10:931938.
94. Martin, E. M.,, T. S. Sullivan,, R. A. Reed,, T. A. Fletcher,, D. L. Pitrak,, W. Weddington, and, M. Harrow. 2001. Auditory working memory in HIV-1 infection. J. Int. Neuropsychol. Soc. 7:2026.
95. Masliah, E.,, C. L. Achim,, N. Ge,, R. DeTeresa,, R. D. Terry, and, C. A. Wiley. 1992a. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann. Neurol. 32:321329.
96. Masliah, E.,, N. Ge,, C. L. Achim,, L. A. Hansen, and, C. A. Wiley. 1992b. Selective neuronal vulnerability in HIV encephalitis. J. Neuropathol. Exp. Neurol. 51:585593.
97. Masliah, E.,, N. Ge,, C. L. Achim, and, C. A. Wiley. 1996. Patterns of neurodegeneration in HIV encephalitis. J. Neuro-AIDS 1:161173.
98. Masliah, E.,, R. K. Heaton,, T. D. Marcotte,, R. J. Ellis,, C. A. Wiley,, M. Mallory,, C. L. Achim,, J. A. McCutchan,, J. A. Nelson,, J. H. Atkinson,, I. Grant, and the HNRC Group. 1997. Dendritic injury is a pathologic substrate for HIV-related cognitive disorders. Ann. Neurol. 42:963972.
99. Mattis, S. 1976. Mental status examination for organic mental syndrome in the elderly patient, p. 77–101. In L. Bellak and, T. E. Karasu (ed.), Geriatric Psychiatry: a Handbook for Psychiatrists and Primary Care Physicians. Grune & Stratton, New York, NY.
100. Mayeux, R.,, Y. Stern,, M.-X. Tang,, G. Todak,, K. Marder,, J. Sano,, M. Richards,, Z. Stein,, A. Ehrhardt, and, J. Gorman. 1993. Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment. Neurology 43:176182.
101. McArthur, J. C. 2004. HIV dementia: an evolving disease. J. Neuroimmunol. 157:310.
102. McArthur, J. C.,, B. A. Cohen,, O. A. Selnes,, A. J. Kumar,, K. Cooper,, J. H. McArthur,, G. Soucy,, D. R. Cornblath,, J. S. Chmiel,, M. Wang,, D. L. Starkey,, H. Ginzburg,, D. G. Ostrow,, R. T. Johnson,, J. P. Phair, and, B. F. Polk. 1989. Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1 infected individuals: results from the Multicenter AIDS Cohort Study. Ann. Neurol. 26:601611.
103. McArthur, J. C.,, and I. Grant. 1998. HIV neurocognitive disorders, p. 499–524. In H. E. Gendelman,, S. Lipton,, L. Epstein, and, S. Swindells (ed.), Neurology of AIDS. Chapman and Hall Publishers, New York, NY.
104. McArthur, J. C.,, D. R. Hoover,, H. Bacellar,, E. N. Miller,, B. A. Cohen,, J. T. Becker,, N. M. H. Graham,, J. H. McArthur,, O. A. Selnes,, L. P. Jacobson,, B. R. Visscher,, M. Concha, and, A. Saah. 1993. Dementia in AIDS patients: incidence and risk factors. Neurology 43:22452252.
105. McArthur, J. C.,, M. P. McDermott,, D. McClernon,, C. St Hillaire,, K. Conant,, K. Marder,, G. Schifitto,, O. A. Selnes,, N. Sacktor,, Y. Stern,, S. M. Albert,, K. Kieburtz,, J. A. deMarcaida,, B. Cohen, and, L. G. Epstein. 2004. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch. Neurol. 61:16871696.
106. McCutchan, J. A.,, J. W. Wu,, K. Robertson,, S. L. Koletar,, R. J. Ellis,, S. Cohn,, M. Taylor,, S. Woods,, R. Heaton,, J. Currier, and, P. L. Williams. 2007. HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS 21:11091117.
107. Mindt, M.,, M. Cherner,, T. Marcotte,, D. Moore,, H. Bentley,, M. Esquivel,, Y. Lopez,, I. Grant, and, R. Heaton. 2003. The functional impact of HIV-associated neuropsychological impairment in Spanish-speaking adults: a pilot study. J. Clin. Exp. Neuropsychol. 25:122132.
108. Morgan, E. E.,, S. P. Woods,, J. C. Scott,, M. Childers,, J. M. Beck,, R. J. Ellis,, I. Grant,, R. K. Heaton, and the HNRC Group. 2008. Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale. J. Clin. Exp. Neuropsychol. 30:8390.
109. Myers, R. S.,, K. K. Ball,, T. D. Kalina,, D. L. Roth, and, K. T. Goode. 2000. Relation of useful field of view and other screening tests to on-road driving performance. Percept. Mot. Skills 91:279290.
110. Navia, B. A.,, E.-S. Cho,, C. K. Petito, and, R. W. Price. 1986a. The AIDS dementia complex: II. Neuropathology. Ann. Neurol. 19:525535.
111. Navia, B. A.,, U. Dafni,, D. Simpson,, T. Tucker,, E. Singer,, J. C. McArthur,, C. Yiannoutsos,, L. Zaborski,, S. A. Lipton,and the AIDS Clinical Trial Group. 1998. A phase I/II trial of nimodipine for HIV-related neurologic complications. Neurology 51:221228.
112. Navia, B. A.,, B. D. Jordan, and, R. W. Price. 1986b. The AIDS dementia complex: I. Clinical features. Ann. Neurol. 19:517524.
113. Neuenburg, J. K.,, H. R. Brodt,, B. G. Herndier,, M. Bickel,, P. Bacchetti,, R. W. Price,, R. M. Grant, and, W. Schlote. 2002. HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 31:171177.
114. Osowiecki, D. M.,, R. A. Cohen,, K. M. Morrow,, R. H. Paul,, C. C. Carpenter,, T. Flanigan, and, R. J. Boland. 2000. Neurocognitive and psychological contributions to quality of life in HIV-1-infected women. AIDS 14:13271332.
115. Owsley, C.,, K. Ball,, G. McGwin, Jr.,, M. E. Sloane,, D. L. Roenker,, M. White, and, T. Overley. 1998. Visual processing impairment and risk of motor vehicle crash among older adults. JAMA 279:10831088.
116. Parsons, T. D.,, K. A. Tucker,, C. D. Hall,, W. T. Robertson,, J. J. Eron,, M. W. Fried, and, K. R. Robertson. 2006. Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection. AIDS 20:15911595.
117. Peavy, G.,, D. Jacobs,, D. P. Salmon,, N. Butters,, D. C. Delis,, M. Taylor,, P. Massman,, J. C. Stout,, W. G. Heindel,, D. Kirson,, J. H. Atkinson,, J. L. Chandler, and, I. Grant. 1994. Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. J. Clin. Exp. Neuropsychol. 16:508523.
118. Piatt, A. L.,, J. A. Fields,, A. M. Paolo, and, A. I. Troster. 1999. Action (verb naming) fluency as an executive function measure: convergent and divergent evidence of validity. Neuropsychologia 37:14991503.
119. Pillai, S. K.,, S. L. Pond,, Y. Liu,, B. M. Good,, M. C. Strain,, R. J. Ellis,, S. Letendre,, D. M. Smith,, H. F. Gunthard,, I. Grant,, T. D. Marcotte,, J. A. McCutchan,, D. D. Richman, and, J. K. Wong. 2006. Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain 129:18721883.
120. Podraza, A. M.,, R. A. Bornstein,, C. C. Whitacre,, M. F. Para,, R. J. Fass,, R. R. Rice, Jr., and, H. A. Nasrallah. 1994. Neuropsychological performance and CD4 levels in HIV-1 asymptomatic infection. J. Clin. Exp. Neuropsychol. 16:777783.
121. Porter, K.,, A. Babiker,, K. Bhaskaran,, J. Darbyshire,, P. Pezzotti, and, A. S. Walker. 2003. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet 362:12671274.
122. Power, C.,, O. A. Selnes,, J. A. Grim, and, J. C. McArthur. 1995. HIV Dementia Scale: a rapid screening test. J. Acquir. Immune Defic. Syndr. 8:273278.
123. Rabkin, J. G.,, and S. Ferrando. 1997. A ‘second life’ agenda. Psychiatric research issues raised by protease inhibitor treatments for people with the human immunodeficiency virus or the acquired immunodeficiency syndrome. Arch. Gen. Psychiatry 54:10491053.
124. Rippeth, J. D.,, R. K. Heaton,, C. L. Carey,, T. D. Marcotte,, D. J. Moore,, R. Gonzalez,, T. Wolfson,, I. Grant, and the HNRC Group. 2004. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J. Int. Neuropsychol. Soc. 10:114.
125. Robertson, K. R.,, W. T. Robertson,, S. Ford,, D. Watson,, S. Fiscus,, A. G. Harp, and, C. D. Hall. 2004. Highly active antiretroviral therapy improves neurocognitive functioning. J. Acquir. Immune Defic. Syndr. 36:562566.
126. Robertson, K. R.,, M. Smurzynski,, T. D. Parsons,, K. Wu,, R. J. Bosch,, J. Wu,, J. C. McArthur,, A. C. Collier,, S. R. Evans, and, R. J. Ellis. 2007. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 21:19151921.
127. Rourke, S. B.,, M. H. Halman, and, C. Bassel. 1999. Neuropsychiatric correlates of memory-metamemory dissociations in HIV-infection. J. Clin. Exp. Neuropsychol. 21:757768.
128. Ryan, E. L.,, S. Morgello,, K. Isaacs,, M. Naseer, and, P. Gerits. 2004. Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology 62:957962.
129. Sacktor, N.,, R. H. Lyles,, R. Skolasky,, C. Kleeberger,, O. A. Selnes,, E. N. Miller,, J. T. Becker,, B. Cohen, and, J. C. McArthur. 2001. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998. Neurology 56:257260.
130. Sacktor, N.,, M. P. McDermott,, K. Marder,, G. Schifitto,, O. A. Selnes,, J. C. McArthur,, Y. Stern,, S. Albert,, D. Palumbo,, K. Kieburtz,, J. A. De Marcaida,, B. Cohen, and, L. Epstein. 2002. HIV-associated cognitive impairment before and after the advent of combination therapy. J. Neurovirol. 8:136142.
131. Sacktor, N.,, N. Nakasujja,, R. Skolasky,, K. Robertson,, M. Wong,, S. Musisi,, A. Ronald, and, E. Katabira. 2006. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology 67:311314.
132. Sacktor, N. C.,, H. Bacellar,, D. R. Hoover,, T. E. Nance-Sproson,, O. A. Selnes,, E. N. Miller,, G. J. Dal Pan,, C. Kleeberger,, A. Brown,, A. Saah, and, J. C. McArthur. 1996. Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. J. Neurovirol. 2:404410.
133. Selnes, O. A.,, J. H. McArthur,, R. Fox,, D. Starkey,, E. N. Miller, and, J. C. McArthur. 1990. Frontal lobe functioning in asymptomatic HIV-infection. Neurology 40(Suppl. 1):237.
134. Sevigny, J. J.,, S. M. Albert,, M. P. McDermott,, J. C. McArthur,, N. Sacktor,, K. Conant,, G. Schifitto,, O. A. Selnes,, Y. Stern,, D. R. McClernon,, D. Palumbo,, K. Kieburtz,, G. Riggs,, B. Cohen,, L. G. Epstein, and, K. Marder. 2004. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology 63:20842090.
135. Sidtis, J. J. 1994. Evaluation of the AIDS dementia complex in adults, p. 273–287. In R. W. Price and, S. W. Perry (ed.), HIV AIDS and the Brain. Raven, New York, NY.
136. Smith, C. A.,, W. G. van Gorp,, E. R. Ryan,, S. J. Ferrando, and, J. Rabkin. 2003. Screening subtle HIV-related cognitive dysfunction: the clinical utility of the HIV dementia scale. J. Acquir. Immune Defic. Syndr. 33:116118.
137. Sonnerborg, A. B.,, A. C. Ehrnst,, S. K. Bergdahl,, P. O. Pehrson,, B. R. Skoldenberg, and, O. O. Strannegard. 1988. HIV isolation from cerebrospinal fluid in relation to immunological deficiency and neurological symptoms. AIDS 2:8993.
138. Spreen, O.,, and E. Strauss. 1998. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary, 2nd ed. Oxford University Press, New York, NY.
139. Stankoff, B.,, V. Calvez,, S. Suarez,, P. Bossi,, O. Rosenblum,, L. Conquy,, E. Turell,, T. Dubard,, A. Coutellier,, L. Baril,, F. Bricaire,, L. Lacomblez, and, C. Lubetzki. 1999. Plasma and cerebrospinal fluid human immunodeficiency virus type-1 (HIV-1) RNA levels in HIV-related cognitive impairment. Eur. J. Neurol. 6:669675.
140. Stern, Y.,, K. Marder,, K. Bell,, J. Chen,, G. Dooneief,, S. Goldstein,, D. Mindry,, M. Richards,, M. Sano,, J. Williams,, J. Gorman,, A. Ehrhardt, and, R. Mayeux. 1991. Multidisciplinary assessment of homosexual men with and without human immunodeficiency virus infection. III. Neurologic and neuropsychological findings. Arch. Gen. Psychiatry 48:131138.
141. Suarez, S.,, L. Baril,, B. Stankoff,, M. Khellaf,, B. Dubois,, C. Lubetzki,, F. Bricaire, and, J. J. Hauw. 2001. Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy. AIDS 15:195200.
142. Temkin, N. R.,, R. K. Heaton,, I. Grant, and, S. S. Dikmen. 1999. Detecting significant change in neuropsychological test performance: a comparison of four models. J. Int. Neuropsychol. Soc. 5:357369.
143. Tombaugh, T. 1997. TOMM: Test of Memory Malingering Manual. Multi-Health Systems, Toronto, Canada.
144. Tozzi, V.,, P. Balestra,, S. Galgani,, P. Narciso,, F. Ferri,, G. Sebastiani,, C. D’Amato,, C. Affricano,, F. Pigorini,, F. M. Pau,, A. De Felici, and, A. Benedetto. 1999. Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. AIDS 13:18891897.
145. Tozzi, V.,, P. Balestra,, S. Galgani,, P. Narciso,, A. Sampaolesi,, A. Antinori,, M. Giulianelli,, D. Serraino, and, G. Ippolito. 2001. Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years. J. Acquir. Immune Defic. Syndr. 28:1927.
146. Tozzi, V.,, P. Balestra,, R. Murri,, S. Galgani,, R. Bellagamba,, P. Narciso,, A. Antinori,, M. Giulianelli,, G. Tosi,, M. Fantoni,, A. Sampaolesi,, P. Noto,, G. Ippolito, and, A. W. Wu. 2004. Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART. Int. J. STD AIDS 15:254259.
147. Tozzi, V.,, P. Balestra,, D. Serraino,, R. Bellagamba,, A. Corpolongo,, P. Piselli,, P. Lorenzini,, U. Visco-Comandini,, C. Vlassi,, M. E. Quartuccio,, M. Giulianelli,, P. Noto,, S. Galgani,, G. Ippolito,, A. Antinori, and, P. Narciso. 2005. Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART. AIDS Res. Hum. Retrovir. 21:706713.
148. U.S. Department of Labor. 1991. Dictionary of Occupational Titles, 4th ed. U.S. Government Printing Office, Washington, DC.
149. Valcour, V.,, C. Shikuma,, B. Shiramizu,, M. Watters,, P. Poff,, O. Selnes,, P. Holck,, J. Grove, and, N. Sacktor. 2004. Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology 63:822827.
150. Van Gorp, W.,, P. Satz,, C. Hinkin,, O. Selnes,, E. Miller,, J. McArthur,, B. Cohen, and, D. Paz. 1991. Metacognition in HIV-1 seropositive asymptomatic individuals: self-ratings versus objective neuropsychological performance. J. Clin. Exp. Neuropsychol. 13:812819.
151. Van Gorp, W. G.,, J. P. Baerwald,, S. J. Ferrando,, M. C. McElhiney, and, J. G. Rabkin. 1999. The relationship between employment and neuropsychological impairment in HIV infection. J. Int. Neuropsychol. Soc. 5:534539.
152. Vaughn, G.,, and R. Detels. 2007. Protease inhibitors and cardiovascular disease: analysis of the Los Angeles County adult spectrum of disease cohort. AIDS Care 19:492497.
153. Vazquez-Justo, E.,, M. Rodriguez Alvarez, and, M. J. Ferraces Otero. 2003. Influence of depressed mood on neuropsychologic performance in HIV-seropositive drug users. Psychiatry Clin. Neurosci. 57:251258.
154. Visual Resources, Inc. 1998. UFOV Useful Field of View Manual. The Psychological Coporation, Chicago, IL.
155. von Giesen, H. J.,, T. Heintges,, N. Abbasi-Boroudjeni,, S. Kucukkoylu,, H. Koller,, B. A. Haslinger,, M. Oette, and, G. Arendt. 2004. Psychomotor slowing in hepatitis C and HIV infection. J. Acquir. Immune Defic. Syndr. 35:131137.
156. Wechsler, D. 1997. WAIS-III: Administration and Scoring Manual. The Psychological Corporation, San Antonio, TX.
157. White, D. A.,, R. K. Heaton, and, A. U. Monsch. 1995. Neuropsychological studies of asymptomatic human immunodeficiency virus-type 1-infected individuals. J. Int. Neuropsychol. Soc. 1:304315.
158. Wiley, C.,, E. Masliah,, M. Morey,, C. Lemere,, R. DeTeresa,, M. Grafe,, L. Hansen, and, R. Terry. 1991. Neocortical damage during HIV infection. Ann. Neurol. 29:651657.
159. Wiley, C. A.,, and C. Achim. 1994. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome Ann. Neurol. 36:673676. (Erratum, 37: 140.)
160. Wilkie, F. L.,, K. Goodkin,, C. Eisdorfer,, D. Feaster,, R. Morgan,, M. A. Fletcher,, N. Blaney,, M. Baum, and, J. Szapocznik. 1998. Mild cognitive impairment and risk of mortality in HIV-1 infection. J. Neuropsychiatry Clin. Neurosci. 10:125132.
161. Wilkins, J. W.,, K. R. Robertson,, C. R. Snyder,, W. K. Robertson,, C. van der Horst, and, C. D. Hall. 1991. Implications of self-reported cognitive and motor dysfunction in HIV-positive patients. Am. J. Psychiatry 148:641643.
162. Woods, S. P.,, C. L. Carey,, A. I. Troster,, I. Grant, and the HNRC Group. 2005. Action (verb) generation in HIV-1 infection. Neuropsychologia 43:11441151.
163. Woods, S. P.,, and I. Grant. 2005. Neuropsychology of HIV, p. 357–373. In H. Gendelman,, I. Grant,, I. Everall,, S. Lipton, and, S. Swindells (ed.), The Neurology of AIDS, 2nd ed. Oxford University Press, London, United Kingsom.
164. Woods, S. P.,, J. D. Rippeth,, A. B. Frol,, J. K. Levy,, E. Ryan,, V. M. Soukup,, C. H. Hinkin,, D. Lazzaretto,, M. Cherner,, T. D. Marcotte,, B. B. Gelman,, S. Morgello,, E. J. Singer,, I. Grant, and, R. K. Heaton. 2004. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J. Clin. Exp. Neuropsychol. 26:759778.

Tables

Generic image for table
TABLE 1

Neuropsychological tests in the current HNRC battery

Citation: Marcotte T, Scott J. 2009. Evolution of Neuropsychological Issues in HIV-1 Infection during the HAART Era, p 29-44. In Goodkin K, Shapshak P, Verma A (ed), The Spectrum of Neuro-AIDS Disorders. ASM Press, Washington, DC. doi: 10.1128/9781555815691.ch2

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error